Skip to main content

Find Clinical Trials

Home
Conditions
Atherosclerotic Cardiovascular Disease

Clinical trial condition

Atherosclerotic Cardiovascular Disease

Explore clinical trials studying Atherosclerotic Cardiovascular Disease. Study availability and eligibility vary by location and protocol.

73 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Atherosclerotic Cardiovascular Disease trial results

Recruiting

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

NCT07037433

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +11 more
Locations: Alliance For Multispecialty Research - Daphne Daphne, Alabama, United States

Eastern Shore Research Institute Fairhope, Alabama, United States

Heart Center Research LLC Huntsville, Alabama, United States

Mobile Heart Specialists PC Mobile, Alabama, United States

View all 782 locations

View Trial Details

Recruiting

A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

NCT07543731

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
Locations: Novartis Basel, Switzerland

View Trial Details

Recruiting

Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

NCT05705804

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +7 more
Locations: Yonsei University Health System, Severance Hospital Seoul, South Korea

View Trial Details

Recruiting

Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Followed by an Open-label Patient Cohort

NCT06813339

Conditions: Acute Coronary Syndrome, Acute Coronary Syndromes, Arterial Occlusive Diseases, +7 more
Locations: CMAX Clinical Research Adelaide, South Australia, Australia

View Trial Details

Recruiting

A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease

NCT07551492

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +3 more
Locations: Fuwai Hospital, CAMS&PUMC Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia

NCT07034690

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +7 more
Locations: Novartis Investigative Site Abu Dhabi, United Arab Emirates

View Trial Details

Recruiting

Fish Oil, Metformin and Heart Health in PCOS

NCT06424860

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +13 more
Locations: Human Nutrition Research Unit - Li Ka Shing Health Research Center Edmonton, Alberta, Canada

Mazankowski Alberta Heart Institute Edmonton, Alberta, Canada

University of Alberta Hospital - Division of Endocrinology Edmonton, Alberta, Canada

View Trial Details

Recruiting

Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure

NCT06962488

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +10 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

NCT06858332

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +3 more
Locations: Novartis Investigative Site Chelyabinsk, Russia

Novartis Investigative Site Chelyabinsk, Russia

Novartis Investigative Site Kaluga, Russia

Novartis Investigative Site Kemerovo, Russia

View all 20 locations

View Trial Details

Recruiting

A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients

NCT06571162

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +3 more
Locations: Intermountain Healthcare Hospitals and Clinics Salt Lake City, Utah, United States

View Trial Details